Dosage and administration
- Cleanse the skin area, and allow to dry. - Shake bottle well before use. - Spray 4-6 inches from skin. No rub-in is required. - Apply liberally as often as necessary to soothe and protect irritated skin.
- Cleanse the skin area, and allow to dry. - Shake bottle well before use. - Spray 4-6 inches from skin. No rub-in is required. - Apply liberally as often as necessary to soothe and protect irritated skin.
Bacitracin 500 units/g
Dimethicone 20%
Petrolatum 25%
Antibacterial / Skin Protectant
- Do not use over deep or puncture wounds, infections, or lacerations. Do not apply over large areas of the body.
- When using this product do not get into eyes. If contact occurs, rinse eyes thoroughly with water. For external use only.
- Stop use and ask a doctor if condition worsens or does not improve in 7 days..
- Cleanse the skin area, and allow to dry.
- Shake bottle well before use.
- Spray 4-6 inches from skin. No rub-in is required.
- Apply liberally as often as necessary to soothe and protect irritated skin.
Cyclomethicone, Hexamethyldisiloxane, Lanolin, Light Mineral Oil, Microcrystalline Wax, Vitamin A Palmitate, Vitamin D3, Water, White Petrolatum
- Keep out of reach of children. If swallowed, get medical help or contact a local poison control center immediately.
Uses: First aid to help prevent infection in minor cuts, scrapes, and burns. Treats and prevents minor skin irritation: itching, diaper rash, feeding tube sites, cuts, and minor burns.
Enter section text here
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1089113 | bacitracin 500 UNT/GM / dimethicone 20 % / zinc oxide 25 % Topical Spray | PSN | 2 |
| 1089117 | RASH RELIEF Antibacterial 500 UNT/GM / 20 % / 25 % Topical Spray | PSN | 2 |
| 1089117 | bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical Spray [Rash Relief Antibacterial] | SBD | 2 |
| 1089113 | bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical Spray | SCD | 2 |
| 1089113 | bacitracin 0.5 UNT/ML / dimethicone 20 % / zinc oxide 25 % Topical Spray | SY | 2 |
| 1089113 | Bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / ZNO 250 MG/ML Topical Spray | SY | 2 |
| 1089117 | Bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / ZNO 250 MG/ML Topical Spray [Rash Relief Antibacterial] | SY | 2 |
| 1089117 | Rash Relief Antibacterial (bacitracin 0.5 UNT/ML / dimethicone 20 % / zinc oxide 25 % ) Topical Spray | SY | 2 |
| Class | Version | Type | Effective |
|---|---|---|---|
| BACITRACIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| 60c52429-fcef-eb54-2387-43bc9e4f296b | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 15071-672-11 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b6d5-f6ea-e053-dbdaa90aa703 | RASH RELIEF ANTIBACTERIAL SPRAY |
| 15071-672-22 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b6d5-f6ea-e053-dbdaa90aa703 | RASH RELIEF ANTIBACTERIAL SPRAY |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 15071-672-11 | Rash Relief Antibacterial | 28 g in 1 BOTTLE | LIQUID | 28 | 2 | |
| 15071-672-22 | Rash Relief Antibacterial | 44 g in 1 BOTTLE | LIQUID | 44 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Bacitracin | ACTIVE INGREDIENT | 58H6RWO52I | 2 | |
| Dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | 2 | |
| Dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 2 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 2 | |
| Cholecalciferol | INACTIVE INGREDIENT | 1C6V77QF41 | 2 | |
| Cyclomethicone | INACTIVE INGREDIENT | NMQ347994Z | 2 | |
| Hexamethyldisiloxane | INACTIVE INGREDIENT | D7M4659BPU | 2 | |
| Lanolin | INACTIVE INGREDIENT | 7EV65EAW6H | 2 | |
| Microcrystalline Wax | INACTIVE INGREDIENT | XOF597Q3KY | 2 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 2 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| Vitamin a palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 15071-672 | 15071-672-11, 15071-672-22 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Bacitracin | 58H6RWO52I | ACTIB |
| Dimethicone | 92RU3N3Y1O | ACTIB |
| Zinc Oxide | SOI2LOH54Z | ACTIB |
| Cyclomethicone | NMQ347994Z | IACT |
| Mineral Oil | T5L8T28FGP | IACT |
| Lanolin | 7EV65EAW6H | IACT |
| Microcrystalline Wax | XOF597Q3KY | IACT |
| Hexamethyldisiloxane | D7M4659BPU | IACT |
| Water | 059QF0KO0R | IACT |
| Cholecalciferol | 1C6V77QF41 | IACT |
| Vitamin a palmitate | 1D1K0N0VVC | IACT |
| Petrolatum | 4T6H12BN9U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | SOLUTION / TOPICAL | 11.57 %w/v | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | AEROSOL, FOAM / TOPICAL | 5.26 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| Microcrystalline Wax | MICROCRYSTALLINE WAX | XOF597Q3KY | OINTMENT / TOPICAL | 3575 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | LOTION / TOPICAL | 1.5 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| Microcrystalline Wax | MICROCRYSTALLINE WAX | XOF597Q3KY | CREAM / VAGINAL | 23 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / AURICULAR (OTIC) | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| Lanolin | LANOLIN | 7EV65EAW6H | SPRAY / NASAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / RECTAL | 105 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | CREAM / TOPICAL | 10 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| Microcrystalline Wax | MICROCRYSTALLINE WAX | XOF597Q3KY | GEL / TOPICAL | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | CREAM, AUGMENTED / TOPICAL | 7.6 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| Microcrystalline Wax | MICROCRYSTALLINE WAX | XOF597Q3KY | CAPSULE, EXTENDED RELEASE / ORAL | 6 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| Lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / OPHTHALMIC | 3 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 24e155fd-dad7-4d37-a12d-0c18fc624481 | f439fb97-0722-42ee-bc90-67daf0497aa8 | 2011-11-16 | Warnings | 24e155fd-dad7-4d37-a12d-0c18fc624481 f439fb97-0722-42ee-bc90-67daf0497aa8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.